Biogen Inc. Completes Acquisition of Human Immunology Biosciences (HI-Bio™)

Biogen Inc. has completed the acquisition of Human Immunology Biosciences (HI-Bio™), a privately-held clinical-stage biotechnology company foc...

July 03, 2024 | Wednesday | News
Merck and and Orion Announce Exercise of Option for Exclusive Global License of Opevesostat, Advancing Prostate Cancer Treatment

Merck  known as MSD outside of the United States and Canada, and Orion Corporation announced that notice has been provided of the mutual exercise of...

July 02, 2024 | Tuesday | News
Bio-Rad Launches Celselect Slides 2.0 to Enhance Rare Cell and CTC Capture

Bio-Rad Laboratories,  a global leader in life science research and clinical diagnostics products, today announced the launch of Celselect Slides 2....

July 01, 2024 | Monday | News
AbbVie Acquires Celsius Therapeutics to Advance Innovative IBD Treatments

AbbVie (NYSE: ABBV) announced  the acquisition of Celsius Therapeutics, Inc. ("Celsius"), a privately held biotechnology company pioneering new...

June 28, 2024 | Friday | News
Thermo Fisher Scientific’s PPD Clinical Research Business to Expand Kentucky Labs, Adding Over 250 Jobs

The PPD clinical research business will nearly double its laboratory footprint in northern Kentucky, add more than 250 jobs The PPD clinical research bu...

June 28, 2024 | Friday | News
Bio-Rad Laboratories Launches New Anti-Idiotypic and Anti-MMAE Antibodies for Enhanced Bioanalytical Assays

  Bio-Rad Laboratories,  a global leader in life science research and clinical diagnostics products, today launched four new anti-idiotypic anti...

June 25, 2024 | Tuesday | News
Bora Pharmaceuticals Expands US Presence with Acquisition of Emergent BioSolutions’ Sterile Manufacturing Facility in Baltimore

Bora Pharmaceuticals Co., Ltd.  announced that it has successfully entered into an agreement for Emergent BioSolutions’  sterile man...

June 21, 2024 | Friday | News
AbbVie’s SKYRIZI® Gains FDA Approval for Moderate to Severe Ulcerative Colitis and Crohn's Disease Following Successful Phase 3 Trials

AbbVie announced that the U.S. Food and Drug Administration (FDA) has approved SKYRIZI® (risankizumab-rzaa) for adults with moderately to severely ac...

June 20, 2024 | Thursday | News
Thermo Fisher Scientific Launches State-of-the-Art Clinical Research Lab in Wisconsin

The PPD clinical research business of Thermo Fisher Scientific Inc., the world leader in serving science, unveiled a new clinical research laboratory build...

June 18, 2024 | Tuesday | News
RevOpsis and Kemwell Partner to Accelerate Development of RO-104 for nAMD

Partnership to accelerate development of lead product candidate, RO-104; a first-in-class tri-specific biologic for treating neovascular age-relat...

June 18, 2024 | Tuesday | News
Thermo Fisher Scientific's PPD Clinical Research Business Earns 13th Consecutive CRO Leadership Award

The PPD clinical research business of Thermo Fisher Scientific Inc., the world leader in serving science, is embracing the theme of the 60th annual Drug ...

June 17, 2024 | Monday | News
Biosplice Therapeutics and Novo Nordisk Partner to Develop Innovative Diabetes Treatments Targeting DYRK Inhibition

  Biosplice Therapeutics, Inc. (“Biosplice”), a clinical-stage biotechnology company pioneering first-in-class therapeutics based on smal...

June 13, 2024 | Thursday | News
ValGenesis and Célere Partner to Deliver Advanced Digital Validation Solutions

ValGenesis Inc., the market leader in enterprise validation lifecycle management systems (VLMS), and Célere, a life sciences-focused consultancy i...

June 12, 2024 | Wednesday | News
Integrated DNA Technologies Unveils Avian Influenza A (H5) Detection Kit Amid Rising H5N1 Concerns in Dairy Cows

Amidst growing concerns from U.S. federal, state and local agencies over Highly Pathogenic Avian Influenza (HPAI) A (H5N1) detections in dairy cows, Inte...

June 11, 2024 | Tuesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close